Sangamo Therapeutics Inc., a genomic medicine company, has entered into a license agreement with Eli Lilly and Company.

Programs will leverage ABL Bio's Grabody-B platform technology to deliver molecules across the blood-brain barrier.

George Clinical, a clinical research organization operating worldwide, has rebranded to become Emerald Clinical Trials.

Veranova has appointed Dr. Scott Zugel as Global Vice President of Analytical Research Development Operations.

The investment will focus on enhancing infrastructure and technology across all logistics touchpoints, creating resilient, ...

Ethris, a clinical-stage biotechnology company creating RNA therapeutics and vaccines, and Lonza entered a collaboration to ...

EPYSQLI is designed to treat gMG in adults who are anti-acetylcholine receptor antibody positive.

Aldeyra received a Complete Response Letter from the U.S. Food and Drug Administration (FDA) for the resubmission of the NDA ...

Tjoapack has launched its Customer Collaboration Dashboard, a digital platform designed to streamline collaboration between ...

Oncodesign Services has appointed Dr. Aidan Synnott as Chief Executive Officer, to help strengthen its position as a trusted partner in drug discovery.

EMAS Pharma has rebranded as Evestia Clinical as it sets its sights on rapid growth as a provider of clinical research in oncology and rare diseases.

In this exclusive webinar, experts from August Bioservices will discuss the critical factors that make or break a successful ...